Achieve Life Sciences, Inc. (ACHV)
5.57
+0.05
(+0.91%)
USD |
NASDAQ |
Jan 14, 11:22
Achieve Life Sciences Research and Development Expense (Quarterly): 5.32M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| StimCell Energetics, Inc. | 0.0573M |
| Venus Concept, Inc. | 1.28M |
| Oncolytics Biotech, Inc. | 5.456M |
| Aurinia Pharmaceuticals, Inc. | 8.435M |
| Edesa Biotech, Inc. | 1.226M |